GemVax&KAEL Co.Ltd (082270) - Cash Flow Conversion Efficiency
Based on the latest financial reports, GemVax&KAEL Co.Ltd (082270) has a cash flow conversion efficiency ratio of 0.181x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.34 Billion ≈ $7.01 Million USD) by net assets (₩57.23 Billion ≈ $38.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of GemVax&KAEL Co.Ltd to measure how many days the company can operate on defensive assets alone.
GemVax&KAEL Co.Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)
This chart illustrates how GemVax&KAEL Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
GemVax&KAEL Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GemVax&KAEL Co.Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Castro
TA:CAST
|
-0.018x |
|
Dagang Nexchange Bhd
KLSE:4456
|
0.009x |
|
Vetropack Holding SA
SW:VETN
|
0.157x |
|
GFPT Public Company Limited
BK:GFPT
|
-0.001x |
|
Beijing E-techstar Co Ltd
SHE:300513
|
-0.096x |
|
IVF Hartmann Holding AG
SW:VBSN
|
0.014x |
|
Eupraxia Pharmaceuticals Inc
TO:EPRX
|
-0.037x |
|
Corem Property Group AB (publ)
ST:CORE-B
|
0.001x |
Annual Cash Flow Conversion Efficiency for GemVax&KAEL Co.Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of GemVax&KAEL Co.Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see GemVax&KAEL Co.Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩57.23 Billion ≈ $38.78 Million |
₩1.11 Billion ≈ $751.21K |
0.019x | +101.98% |
| 2024-12-31 | ₩29.01 Billion ≈ $19.66 Million |
₩-28.37 Billion ≈ $-19.23 Million |
-0.978x | -3062.96% |
| 2023-12-31 | ₩108.02 Billion ≈ $73.20 Million |
₩3.57 Billion ≈ $2.42 Million |
0.033x | +250.07% |
| 2022-12-31 | ₩134.35 Billion ≈ $91.05 Million |
₩-2.96 Billion ≈ $-2.00 Million |
-0.022x | +2.30% |
| 2021-12-31 | ₩153.99 Billion ≈ $104.35 Million |
₩-3.47 Billion ≈ $-2.35 Million |
-0.023x | -121.81% |
| 2020-12-31 | ₩135.21 Billion ≈ $91.63 Million |
₩13.95 Billion ≈ $9.46 Million |
0.103x | +1476.21% |
| 2019-12-31 | ₩94.95 Billion ≈ $64.35 Million |
₩-712.11 Million ≈ $-482.58K |
-0.007x | -233.67% |
| 2018-12-31 | ₩113.81 Billion ≈ $77.13 Million |
₩-255.80 Million ≈ $-173.36K |
-0.002x | -140.30% |
| 2017-12-31 | ₩66.94 Billion ≈ $45.37 Million |
₩-62.62 Million ≈ $-42.43K |
-0.001x | +99.61% |
| 2016-12-31 | ₩53.43 Billion ≈ $36.21 Million |
₩-12.68 Billion ≈ $-8.59 Million |
-0.237x | -105.98% |
| 2015-12-31 | ₩47.70 Billion ≈ $32.33 Million |
₩-5.50 Billion ≈ $-3.73 Million |
-0.115x | -147.60% |
| 2014-12-31 | ₩43.94 Billion ≈ $29.77 Million |
₩10.64 Billion ≈ $7.21 Million |
0.242x | +140.91% |
| 2011-12-31 | ₩73.88 Billion ≈ $50.07 Million |
₩7.42 Billion ≈ $5.03 Million |
0.100x | -- |
About GemVax&KAEL Co.Ltd
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution p… Read more